Latest Breaking News On - Medication preferences - Page 1 : vimarsana.com

/PRNewswire/ Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present new data on treatment patterns and unmet needs in adult and.

United statesEiryw robertsNeurocrine biosciencesAcademy of managed care pharmacyDrug administrationPrnewswire neurocrine biosciences incManaged care pharmacyChief medical officerUnmet needsClassic congenital adrenal hyperplasiaModified delphi consensusResource utilizationClassic congenital adrenalMedication preferencesDiscrete choice